Antares Pharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Antares Pharma, Inc. (Antares or 'the company') is a drug device company that develops and markets self-injection pharmaceutical products and technologies. The company develops these products with its partners and is designed to provide functional and commercial advantages, such as reduced side effects, improved safety and efficacy and enhanced patient comfort and adherence. Its major technology includes VIBEX and VIBEX QuickShot pressure-assisted auto-injector systems. The company sells its products under VIBEX, ELESTRIN, and XYOSTED brand names. It also manages partnerships with various pharmaceutical companies to advance various product development programs. The company operates in the US, Europe and other regions worldwide. The company is headquartered in Ewing, New Jersey, the US.Scope
- Detailed information on Antares Pharma, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Antares Pharma, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Antares Pharma, Inc. including a breakdown and examination of key business segments
- Intelligence on Antares Pharma, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Antares Pharma, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Antares Pharma, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Antares Pharma, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Antares Pharma, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Antares Pharma, Inc.: Company Overview
- Antares Pharma, Inc.: Overview and Key Facts
- Antares Pharma, Inc.: Overview
- Antares Pharma, Inc.: Key Facts
- Antares Pharma, Inc.: Key Employees
- Antares Pharma, Inc.: Key Employee Biographies
- Antares Pharma, Inc.: Major Products and Services
- Antares Pharma, Inc.: Management Statement
- Antares Pharma, Inc.: Locations and Subsidiaries
- Antares Pharma, Inc.: Key Competitors
- Antares Pharma, Inc.: Company Analysis
- Antares Pharma, Inc.: Business Description
- Antares Pharma, Inc.: SWOT Analysis
- Antares Pharma, Inc.: SWOT Overview
- Antares Pharma, Inc.: Strengths
- Antares Pharma, Inc.: Weaknesses
- Antares Pharma, Inc.: Opportunities
- Antares Pharma, Inc.: Threats
- Antares Pharma, Inc.: Corporate Financial Deals Activity
- Antares Pharma, Inc.: Financial Deals Overview
- Antares Pharma, Inc.: Targets and Partners
- Antares Pharma, Inc.: Top Deals 2019 - 2023YTD*
- Antares Pharma, Inc.: Advisors
- Antares Pharma, Inc.: Top Legal Advisors
- Antares Pharma, Inc.: Top Financial Advisors
- Antares Pharma, Inc.: Partnership
- Antares Pharma, Inc.: Divestments
- Antares Pharma, Inc.: Private Equity and Ownership
- Antares Pharma, Inc.: Recent Developments
- Antares Pharma, Inc.: News and Events Summary
- Antares Pharma, Inc.: Business Expansion
- Antares Pharma, Inc.: Corporate Governance
- Antares Pharma, Inc.: Financial Performance
- Antares Pharma, Inc.: Market Developments
- Antares Pharma, Inc.: Regulatory and Legal Events
- Antares Pharma, Inc.: Research & Development
- Antares Pharma, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About the Publisher
- Table 1: Antares Pharma, Inc.: Key Facts
- Table 2: Antares Pharma, Inc.: Key Employees
- Table 3: Antares Pharma, Inc.: Locations and Subsidiaries
- Table 4: Antares Pharma, Inc.: Key Competitors
- Table 5: Antares Pharma, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
- Table 6: Antares Pharma, Inc.: Targets and Partners
- Table 7: Antares Pharma, Inc.: Top Deals 2019 - 2023YTD*
- Table 8: Antares Pharma, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 9: Antares Pharma, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 10: Antares Pharma, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
- Table 11: Antares Pharma, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
- Table 12: Antares Pharma, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
- Table 13: Antares Pharma, Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
- Table 14: Antares Pharma, Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
- Table 15: Antares Pharma, Inc.: News and Events Summary
- Table 16: Antares Pharma, Inc.: Business Expansion
- Table 17: Antares Pharma, Inc.: Corporate Governance
- Table 18: Antares Pharma, Inc.: Financial Performance
- Table 19: Antares Pharma, Inc.: Market Developments
- Table 20: Antares Pharma, Inc.: Regulatory and Legal Events
- Table 21: Antares Pharma, Inc.: Research & Development
- Table 22: Antares Pharma, Inc.: Strategy and Operations
- Figure 1: Antares Pharma, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
- Figure 2: Antares Pharma, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
- Figure 3: Antares Pharma, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
- Figure 4: Antares Pharma, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
- Figure 5: Antares Pharma, Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
- Figure 6: Antares Pharma, Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
